Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2000-06-22
2002-11-26
Lankford, Jr., Leon B. (Department: 1651)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S373000, C435S378000, C435S401000, C435S001100
Reexamination Certificate
active
06485969
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a basement membrane composition and method for its preparation and use. More particularly, the present invention is directed to the basement membrane of avian and reptile follicles and the use of same to support the growth and differentiation of eukaryotic cells cultured in vitro.
BACKGROUND AND SUMMARY OF THE INVENTION
There has been much research effort directed to finding natural and synthetic materials having the requisite properties for use as cell culture substrates. Cellular morphology and metabolic activity of cultured cells are affected by the composition of the substrate on which they are grown. Presumably cultured cells function best (i.e. proliferate and perform their natural in vivo functions) when cultured on substrates that closely mimic their natural environment.
One biological tissue that can potentially be used to culturing cells is the basement membranes of vertebrate tissues. Basement membranes, also known as basal lamina, are extracellular matrices (ECMs) that compartmentalize tissues and provide important signals for the adhesion, growth, differentiation, migration of cells they support. In addition, basement membranes influence several physiological and pathological processes. Accordingly, complete and intact basement membrane is naturally functions as a substrate for cell proliferation and growth. However, intact basement membranes are not commercially available for research.
The ability of complex substrates to support cell growth in vitro has been previously reported, and matrix products supporting such growth are commercially available. For example, Becton Dickinson currently offers two such products: Human Extracellular Matrix, and MATRIGEL® Basement Membrane Matrix. Human Extracellular Matrix is a chromatographically partially purified matrix extract derived from human placenta and comprises laminin, collagen IV, and heparin sulfate proteoglycan. (Kleinman, H K et al., U.S. Pat. No. 4,829,000 (1989)) MATRIGEL® is a soluble basement membrane extract of the Engelbreth-Holm-Swarm (EHS) tumor, gelled to form a reconstituted basement membrane. Both of these matrix products require costly biochemical isolation, purification, and synthesis techniques and thus production costs are high. In addition these matrix products are reconstituted from extracts of basement membranes and thus do not represent the structure of the basement membrane as it exists in the body.
Accordingly, the study of cellular function by culturing cells in vitro is limited by the availability of cell growth substrates that present the appropriate physiological environment for the proliferation and development of the cultured cells.
The present invention is directed to the use of vertebrate basement tissue-derived matrices as substrates for the growth and attachment of a wide variety of cell types. The extracellular matrices for use in accordance with the present invention comprise highly conserved collagens, glycoproteins, proteoglycans, and glycosaminoglycans in their natural configuration and natural concentration. The extracellular matrix is derived from ovarian follicular tissue of a vertebrate species, and in particular ovarian follicular tissue of vertebrate species that lay eggs.
In accordance with one embodiment, a composition comprising intact basement membrane of follicle tissue of a vertebrate is described. The composition comprises basement membrane is substantially free of cells of the source vertebrate wherein the basement membrane is retained in its natural three dimensional shape. Follicle basement membrane (FBM) prepared in accordance with the present invention is use to induce the proliferation and growth of cells. In one embodiment the invention is directed to a composition and method for culturing eukaryotic cells in vitro.
REFERENCES:
patent: 4829000 (1989-05-01), Kleinman et al.
patent: 4902508 (1990-02-01), Badylak et al.
patent: 4921808 (1990-05-01), Schneyer et al.
patent: 5275826 (1994-01-01), Badylak et al.
patent: 5281422 (1994-01-01), Badylak et al.
patent: 5352463 (1994-10-01), Badylak et al.
patent: 5821121 (1998-10-01), Brothers
patent: 0 218 065 A 2 (1987-04-01), None
“Steroidogenesis and Actions in the Hen Ovary,” by A.L. Johnson, Critical Reviews in Poultry Biology (1990) vol. 2(4), 319-346.
“Crude Liver Membrane Fractions as Substrate Preserve Liver-Specific Functions in Long-Term, Serum-Free Rat Hepatocyte Cultures,” by B. Saad et al., In Vitro Cell Dev. Biol. (1993) vol. 29A, 32-40.
“Crude Liver Membrane Fractions and Extracellular Matrix Components as Substrata Regulate Differentially the Preservation and Inducibility of Cytochrome P-450 Isoenzymes in Cultured Rat Hepatocytes,” by B. Saad et al., Eur. J. Biochem. (1993) vol. 213, 805-814.
“Identification of Multiple Active Growth Factors in Basement Membrane Matrigel Suggests Caution in Interpretation of Cellular Activity Related to Extracellular Matrix Components,” by S. Vukicevic et al., Exp. Cell Res. (1992) vol. 202, 1-8.
“Increased Rate of Peripheral Nerve Regeneration Using Bioresorbable Nerve Guides and a Laminin-Containing Gel,” by Madison et al., Exp. Neurology (1985) vol. 88, 767-772.
“Isolation and Characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma,” by Kleinman et al., Biochemistry (1982) vol. 21, 6188-6193.
“Formation of a Supramolecular Complex is Involved in the Reconstitution of Basement Membrane Components,” by Kleinman et al., Biochemistry (1983) vol. 22, 4969-4974.
“Basement Membrane Complexes With Biological Activity,” by Kleinman et al., Biochemistry (1986) vol. 25(2), 312-318.
“Human Laminin Isolated in a Nearly Intact, Biologically Active Form From Placenta by Limited Proteolysis,” by Wewer et al., J. Biol. Chem. (1983) vol. 258 (20), 12654-12660.
Rakotoarivony et al., Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences D:Sceinces Naturelles 284(7): 565-568 (1977). (Abstract).
Carlson et al. Renal Physiol. (1980) vol. 3(1-6), 280-287. (Abstract).
Meezan et al. Biol. Chem. Basement Membr., [Proc. Int. Symp.] 1st (1978), Meeting Date 1976, 17-30. (Abstract).
Dixit et al., Artif. Organs 16(4): 336-341 (1992). (Abstract).
Gibbons et al., Eur. J. Biochem. 66(2):243-250 (1976). (Abstract).
Asem Elikplimi K.
Robinson J. Paul
Turek John J.
Lankford , Jr. Leon B.
Purdue Research Foundation
LandOfFree
Biomaterial derived from follicle basement membranes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomaterial derived from follicle basement membranes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomaterial derived from follicle basement membranes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2989794